DKK 570.0
(-1.72%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -162.3 Million | 45.93 Million | -88.78 Million | 266.21 Million | 144.4 Million | 12.65 Million |
Net Income | 109.7 Million | 55.75 Million | 72.92 Million | 62.68 Million | 57.38 Million | 67.37 Million |
Depreciation & Amortization | 945 Thousand | 2.58 Million | 5.45 Million | 3.99 Million | -236 Thousand | 1.79 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -245.21 Million | -4.46 Million | -137.2 Million | 221.26 Million | 93.82 Million | -34.2 Million |
Other non-cash items | -27.74 Million | -7.94 Million | -29.95 Million | -21.73 Million | -6.56 Million | -22.3 Million |
Investing Cash Flow | 159.15 Million | -620 Thousand | 2.98 Million | 148 Thousand | -1.58 Million | -3.43 Million |
Investments in PPE | -2.21 Million | -620 Thousand | - | - | -1.58 Million | -3.43 Million |
Acquisitions | 488 Thousand | - | 2.98 Million | 148 Thousand | - | - |
Investment purchases | 2.21 Million | -352.77 Million | -49.61 Million | -219.67 Million | -170.24 Million | -106.92 Million |
Sales/Maturities of investments | 186.94 Million | - | - | - | - | - |
Other Investing Activities | -28.28 Million | 352.77 Million | 49.61 Million | 219.67 Million | 170.24 Million | - |
Financing Cash Flow | 119.31 Million | -16.2 Million | 93.97 Million | -5.4 Million | 44.2 Million | -19.37 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -5.4 Million | -16.2 Million | - | -5.4 Million | -10.8 Million | -5.4 Million |
Common Stock Repurchased | - | - | - | - | - | -25 Million |
Common Stock Issuance | 5 Million | - | - | - | 55 Million | 11.02 Million |
Other Financing Activities | 119.71 Million | 391.51 Million | 93.97 Million | 237.88 Million | 369.76 Million | 1.02 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -245.21 Million | -4.46 Million | -137.2 Million | 221.26 Million | 93.82 Million | -284.82 Million |
Cash at beginning of period | 669.78 Million | 640.67 Million | 726.47 Million | 465.51 Million | 277.66 Million | 287.82 Million |
Cash at end of period | 785.94 Million | 669.78 Million | 640.67 Million | 726.47 Million | 464.68 Million | 277.66 Million |
Capital Expenditure | -2.21 Million | -620 Thousand | - | - | -1.58 Million | -3.43 Million |
Effect of forex changes on cash | - | - | -93.97 Million | - | - | - |
Net cash flow / Change in cash | 116.16 Million | 29.11 Million | -85.8 Million | 260.96 Million | 187.01 Million | -10.15 Million |
Free Cash Flow | -164.51 Million | 45.31 Million | -88.78 Million | 266.21 Million | 142.81 Million | 9.22 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 25.08 Million | 25.23 Million | 109.7 Million | 26.78 Million | 26.78 Million | 30.75 Million |
Depreciation & Amortization | - | - | 945 Thousand | -184.5 Thousand | -184.5 Thousand | 294 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -245.21 Million | -18.01 Million | -18.01 Million | - |
Other non-cash items | -25.08 Million | -25.23 Million | -27.74 Million | -11.74 Million | -11.74 Million | -30.75 Million |
Investing Cash Flow | - | - | 159.15 Million | 94.69 Million | 94.69 Million | - |
Investments in PPE | - | - | -2.21 Million | -130 Thousand | -130 Thousand | - |
Acquisitions | - | - | 488 Thousand | - | - | - |
Investment purchases | - | - | 2.21 Million | - | - | - |
Sales/Maturities of investments | - | - | 186.94 Million | - | - | - |
Other Investing Activities | - | - | -28.28 Million | 94.82 Million | 94.82 Million | - |
Financing Cash Flow | - | - | 119.31 Million | 5.24 Million | 5.24 Million | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | -5.4 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 5 Million | - | - | - |
Other Financing Activities | - | - | 119.71 Million | 5.24 Million | 5.24 Million | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | -245.21 Million | -18.01 Million | -18.01 Million | - |
Cash at beginning of period | - | - | 669.78 Million | - | - | - |
Cash at end of period | - | - | 785.94 Million | 96.78 Million | 454 Thousand | 588 Thousand |
Capital Expenditure | - | - | -2.21 Million | -130 Thousand | -130 Thousand | - |
Effect of forex changes on cash | - | - | - | - | -96.32 Million | - |
Net cash flow / Change in cash | - | - | 116.16 Million | 96.78 Million | 454 Thousand | 588 Thousand |
Free Cash Flow | - | - | -164.51 Million | -3.28 Million | -3.28 Million | 588 Thousand |
HVW
TLOU
8343
PARNAXLAB
EQC-PD
GELGF